Nuclear data for medical applications – Recent developments and future requirements

Cancer treatment represents a major economic and medical issue because of the extensive incidence of the disease worldwide, with a particularly large rate of increase to be found in developing countries. Over the previous twenty years, the International Atomic Energy Agency (IAEA) has dedicated a series of investigations towards identifying and quantifying the production routes and decay characteristics of radioisotopes judged to be of existing and emerging importance in nuclear medicine and radiotherapy. Both the recommendations formulated during the course of these technical debates and the results of recently completed and on-going IAEA coordinated research projects are focused towards the successful evolution of improvements in nuclear data for medical applications throughout the early 21st century.